These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 24543092)
1. Blood dyscrasias; a nationwide survey. WELCH H; LEWIS CN; KERLAN I Antibiot Chemother (Northfield); 1954 Jun; 4(6):607-23. PubMed ID: 24543092 [No Abstract] [Full Text] [Related]
2. Do chloramphenicol blood dyscrasias occur in Hong Kong? Kumana CR; Li KY; Kou M Adverse Drug React Toxicol Rev; 1993; 12(2):97-106. PubMed ID: 8357948 [No Abstract] [Full Text] [Related]
3. Blood dyscrasias and topical ophthalmic chloramphenicol. Fraunfelder FT; Morgan RL; Yunis AA Am J Ophthalmol; 1993 Jun; 115(6):812-3. PubMed ID: 8506918 [No Abstract] [Full Text] [Related]
4. Blood dyscrasias attributed to chloramphenicol: a review of 641 published and unpublished cases. Polak BC; Wesseling H; Schut D; Herxheimer A Postgrad Med J; 1974 Oct; 50 Suppl 5():123-6. PubMed ID: 4470805 [No Abstract] [Full Text] [Related]
5. Editorial: Drug-induced blood dyscrasias. N Z Med J; 1973 Sep; 79(499):260. PubMed ID: 4519037 [No Abstract] [Full Text] [Related]
6. [Blood damage due to chloramphenicol and thiamphenicol]. Beck EA Schweiz Med Wochenschr; 1975 Aug; 105(34):1078-80. PubMed ID: 1166296 [TBL] [Abstract][Full Text] [Related]
11. [3 cases of blood dyscrasia following treatment with chloramphenicol]. von Rechenberg HK; Batz K Praxis; 1966 Feb; 55(8):214-6. PubMed ID: 5953269 [No Abstract] [Full Text] [Related]
12. Lack of evidence for systemic toxicity following topical chloramphenicol use. Walker S; Diaper CJ; Bowman R; Sweeney G; Seal DV; Kirkness CM Eye (Lond); 1998; 12 ( Pt 5)():875-9. PubMed ID: 10070527 [TBL] [Abstract][Full Text] [Related]
13. Early hematological abnormalities associated with chloramphenicol therapy. Beck EA; Buehler F; Armentrout SA; Lüdin H Helv Med Acta; 1972; 36(4):295-306. PubMed ID: 4636280 [No Abstract] [Full Text] [Related]
14. [Secondary blood dyscrasias due to drugs and chemical agents. Study in patients hospitalized in the Hematology Service of the Hospital das Clínicas of the F.M.U.S.P. from 1955 to 1975]. de Cillo DM; Santana MO; Mori NS; Jamra M Rev Hosp Clin Fac Med Sao Paulo; 1978 Feb; 33(1):33-8. PubMed ID: 307268 [No Abstract] [Full Text] [Related]
15. Should chloramphenicol be used at all? Med J Aust; 1971 Apr; 1(17):928-30. PubMed ID: 5576812 [No Abstract] [Full Text] [Related]
16. Risk of systemic toxicity from topical ophthalmic chloramphenicol. Phillips CI Scott Med J; 2008 Aug; 53(3):54-5. PubMed ID: 18780528 [No Abstract] [Full Text] [Related]
17. Blood dyscrasias associated with chloramphenicol. Hill CG Can Med Assoc J; 1972 Jan; 106(2):147-50, 179. PubMed ID: 5058887 [No Abstract] [Full Text] [Related]
18. Blood dyscrasias associated with chloramphenicol therapy; with a report of two cases. EL-HAMID A J Egypt Med Assoc; 1957; 40(12):895-905. PubMed ID: 13525561 [No Abstract] [Full Text] [Related]
19. Studies on chloramphenicol. II. Possible determinants and progress of haemopoietic toxicity during chloramphenicol therapy. O'Gorman Hughes DW Med J Aust; 1973 Dec; 2(26):1142-6. PubMed ID: 4777551 [No Abstract] [Full Text] [Related]
20. Emergencies in ophthalmology. Hatchuel W S Afr Med J; 1973 Jun; 47(21):896. PubMed ID: 4711001 [No Abstract] [Full Text] [Related] [Next] [New Search]